PROTAC WDR5 degrader 1
PROTAC WDR5 degrader 1 is a heterobifunctional WDR5 PROTAC degrader with a DC50 value of 53 nM and a Kd value of 18 nM, exhibiting selective WDR5 degradation activity and cell permeability. PROTAC WDR5 degrader 1 induces proliferation defects in leukemia cells, with enhanced efficacy in cells overexpressing VHL. PROTAC WDR5 degrader 1 is applicable to research related to acute myeloid leukemia.
(Pink: WDR5 ligand (HY-168488); Blue: VHL ligand (HY-125845); Black: linker (HY-W015878)).
For research use only. We do not sell to patients.
- CAS No.: 2737222-94-3
- Formula: C52H60F3N9O7S
- Molecular Weight:1012.15
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All PROTACs Isoforms
More
Biological Activity
WDR5[1]
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HEK-293T | IC50 |
13600 nM
Compound: EUB0001122a
|
Cellular target engagement assay with: WDR5
Cellular target engagement assay with: WDR5
|
10.6019/CHEMBL5058541 |
| HEK-293T | IC50 |
2150 nM
Compound: EUB0001122a
|
Cellular target engagement assay with: WDR5
Cellular target engagement assay with: WDR5
|
10.6019/CHEMBL5058541 |
PROTAC WDR5 degrader 1 (Compound 8g) exhibits cell permeability and binds to WDR5 in live MV4-11 cells with an IC50 of 13.6 μM; its IC50 for binding to WDR5 in MV4-11 cell lysates is 2.15 μM[1].
PROTAC WDR5 degrader 1 (0.004-10 μM; 24 h) induces dose-dependent degradation of HiBiT-tagged WDR5 in MV4-11WDR5-HiBiT cells, with a DC50 of 0.053 μM and a maximum degradation rate of 58% after 24 h of treatment[1].
PROTAC WDR5 degrader 1 (0.01-10 μM; 24 h) induces dose-dependent depletion of endogenous WDR5 in untreated MV4-11 cells, and a degradative effect lasting 72 h is observed at a concentration of 0.04 μM[1].
PROTAC WDR5 degrader 1 (5-10 μM; 15 days) induces moderate proliferation defects in untreated MV4-11 cells; in MV4-11VHL cells overexpressing VHL, stronger growth inhibition is consistently observed due to enhanced WDR5 degradation efficiency[1].
PROTAC WDR5 degrader 1 mediates the depletion of endogenous WDR5 in HL-60 human leukemia cells and exhibits activity across a variety of cancer cell lines[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Naive MV4-11 cells
-
Concentration:0.01, 0.1, 1 and 10 μM
-
Incubation Time:24 h; 72 h
-
Result:Induced dose-dependent depletion of endogenous WDR5, with efficacy matching that observed for HiBiT-tagged WDR5.
Sustained degradation for up to 72 h post-treatment at 0.04 μM.
-
Cell Line:Naive MV4-11 cells, VHL-overexpressing MV4-11VHL cells
-
Concentration:5 μM, 10 μM
-
Incubation Time:15 days
-
Result:Induced a moderate proliferation defect over 15 days in naive MV4-11 cells at 10 μM.
Induced more pronounced growth defects in VHL-overexpressing MV4-11VHL cells at both 5 μM and 10 μM, correlating with enhanced WDR5 degradation due to increased VHL expression.
Chemical Information
-
CAS No. 2737222-94-3
-
Molecular Weight 1012.15
-
Formula C52H60F3N9O7S
-
SMILES
O=C(C(C(C(F)(F)F)=C1)=CNC1=O)NC2=C(N3CCN(CC3)C)C=CC(C4=CC=C(C=C4)C(NCCCCC(N[C@@H](C(C)(C)C)C(N5[C@@H](C[C@H](C5)O)C(NCC6=CC=C(C7=C(C)N=CS7)C=C6)=O)=O)=O)=O)=C2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)